Constrained medical oxygen supply chain in India during COVID-19: Red-tapism, the elephant in the room?

Constrained medical oxygen supply chain in India during COVID-19: Red-tapism, the elephant in the room? | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Short Report Constrained medical oxygen supply chain in India during COVID-19: Red-tapism, the elephant in the room? Dr. Naveen R Gowda, Dr. Vijaydeep Siddharth, Dr. Parmeshwar Kumar, and 4 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-1120913/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Background: Recent disruption of medical oxygen during second wave of COVID-19 has caused nationwide panic. This study attempts to objectively analyze the medical oxygen supply chain in India along the principles of value stream mapping (VSM), identify bottlenecks and recommend systemic improvements. Methodology: Process mapping of the medical oxygen supply chain in India was done. Different licenses & approvals, their conditions, compliances, renewals among others were factored-in. All relevant circulars, official orders, amendments and gazette notifications pertaining to medical oxygen since April 2020 were studied and corroborated with information from PESO official website. Findings: All steps of medical oxygen supply chain right from oxygen manufacture to filling, storage and transport up to the end users; have regulatory bottlenecks. Consequently flow of materials is sluggish and very poor information flow has aggravated the inherent inefficiencies of the system. Government of India has been loosening regulatory norms at every stage, which is reactive rather than proactive policy making. Discussion: Regulatory bottlenecks have indirectly fuelled the informal sector over the years, which is not under Government’s control. This has also caused difficulties in clamping down black-marketing and hoarding. Technology enabled, data-driven regulatory processes with minimum discretionary human interface is the way to go. Health Economics & Outcomes Research Medical oxygen crisis Regulatory frameworks Value Stream Mapping e-Governance Digital India Ease of doing business Health Policy Health Services Administration Figures Figure 1 Figure 2 Figure 3 Figure 4 Summary Summary Box: What is already known about this subject? Shortage of medical oxygen during the second wave of COVID-19 has caused severe crisis in Indian healthcare. Government of India has taken drastic steps to address the crisis. What does this study add? Value Stream Mapping approach has been used to study the medical oxygen supply chain in India. Insights on regulatory bottlenecks at different levels of medical oxygen supply chain Provides possible reasons behind the ongoing medical oxygen crisis. Proposes plausible long-term systemic solutions for the problem. No such study till date from India, therefore first of its kind. Recommendations for Policy & Practice? The study proposes a technology based data-driven regulatory processes with minimum discretionary human interface. Better ease-of-doing business for the medical oxygen industry. Systemic changes that can further improve regulation and yet keep processes easy for all stakeholders. Can be used to improve government policy making, from reactive to being more proactive. Background Today entire humanity is grappling with the deadly impact of the COVID 19, which is rapidly mutating and changing its nature as it travels across world. Second wave of COVID 19 caught India by complete surprise and policy paralysis has further weakened the situation in the entire country.It has pushed Indian healthcare to the brink. The fast rising pandemic has uncovered many long-standinginherent weaknesses in the Indian healthcare system. Recent disruption in supply of medical oxygen to healthcare establishments has struck at the very heart of the healthcare system and triggered an alarm at the national level. The crisis has put not just the executive & government but also the judiciary into an overdrive. Oxygen from industries has been diverted for medical purposes among many other radical moves and yet the crisis looms big. So, what got us here? As with any disaster situation, there are many schools of thought and needless to say, because of its political ramifications, oversimplifying the problem by vilifying select few stakeholders appears to be an easy way out. Some narratives point to a deficient production capacity, which is not agreed by some experts. Failures to maintain supply chain, a surge in consumption, irrational usage, hoarding among others are vaguely tossed around to be the cause. It is therefore important to have an objective assessment of the system right from the point of production, all the way to the point of consumption/ usage of medical oxygen. This can help us understand the bottlenecks and improvements can be planned at a systemic level to avert future disasters. Value Stream Mapping helps in identifying wasteful activities, improve efficiencyof systems by studying the flow of materials and information. An assessment of the medical oxygen supply chain along this approach can shed more light on the possible causes, which has been done in the current study. Aim To study the medical oxygen supply chain along the principles of value stream mapping, identify bottlenecks and recommend improvements. Methodology Process mapping of medical oxygen supply chain was done with an approach of value stream mapping. It was done in lines with Gas Cylinder Rules 2016 (GCR 2016) and Static & Mobile Pressure Vessels (Unfired) Rules 2016 (SMPV 2016). Different approvals, licenses required, conditions of licenses, renewal of licenses, inspections among others were studied and factored in. All relevant circular, official orders, memos, amendments, Government of India gazette notifications pertaining to medical oxygen from April 2020 were studied and findings incorporated. Relevant information pertaining to each step in the process mapping was taken from PESO (Petroleum & Explosives Safety Organization) official website ( www.peso.gov.in ) and findings incorporated. Results/ Findings Process mapping of medical oxygen supply chain was done. It starts with the manufacture of oxygen, followed by largely two streams viz, oxygen cylinders and liquid oxygen. Figure 1 provides an overview of the entire supply chain along with licenses required/ statutory requirements for each step, right from the point of production all the way to the point of consumption/ end users. The entire system can be studied in 5 parts viz, Manufacture of Oxygen, Manufacture, filling & storage of cylinders, Manufacture, filling & storage of pressure vessels, Transportation and Hospitals/ end users i. Manufacture of oxygen: Demand for medical oxygen during the pandemic has gone up almost four times, from 750MT/day to approx. 2800MT/day. Currently, during the COVID-19 pandemic, around 50% of the total Liquid Oxygen production is being used for medical purpose in comparison to around 15% usage during the pre-COVID period. But the overall production capacity remains more or less the same. The government has taken measures like diversion of oxygen from other industries(1)and floated a global tender for procurement of Liquid Oxygen(2) in an attempt to tide over the immediate crisis. Financial viability of cylinder fillers was under question due to which the ex-factory price of oxygen was recently capped (3). In a desperate attempt to boost overall production capacity, Central Drugs Standard Control Organization (CDSCO) issued circular promising license to manufacturers of industrial oxygen to manufacture medical oxygen within 24 hours of applying, under the Drugs & Cosmetics Act 1940 & Rules(4). Manufacture of oxygen has therefore been tightly controlled ®ulated, which is now being loosened during the crisis. ii. Manufacture, filling & storage of cylinders: Oxygen delivery through cylinders is one of the key modalities of oxygen supply, especially for small hospitals, nursing homes, day care facilities and remote areas. Around 80% of the hospitals in India are less than 50-bedded(5) and most of them would be dependent on oxygen cylinders for their medical oxygen needs. The shortage of oxygen cylinders has become more evident during the pandemic. With only 17 approved high-pressure gas cylinder manufactures(6) and 11 approved multi-function valves manufacturers (7), India is undoubtedly grappling with shortage of oxygen cylinders. Government of India has allowed conversion of use of industrial cylinders for filling medical oxygen and floated tender for immediate procurement of oxygen cylinders in a damage control mode. Figure 2 illustrates the complete process of oxygen supply through cylinders and helps to identify the bottlenecks. The government has also relaxed the restrictions for filling and storage of oxygen cylinders. Filling of oxygen cylinders round-the-clock has been allowed, which was otherwise not allowed without approval. Even the license renewal process has been relaxed to ease the constraints. Obtaining licenses requires clearances from inspecting authorities, which has been a bottleneck for long. Enabling Third Party Inspection Agencies (TPIAs) for this purpose is a welcome step, but so far there are 15 approved TPIAs across the country(8). Not-to-mention the other approvals from district administration, fire authorities, labor norms etc. Seamless flow of information amongst all stakeholders is the lifeline for any industrial systems. The recent circular instructing all the registered facilities to provide a daily update on the inventory status (9)(10) sheds light on the lack of real-time data with the regulators and possibly tells us the reason for the inertia in the system. iii. Manufacture, filling & storage of pressure vessels: The other important source for larger hospitals and establishments is the liquid oxygen (LOX), which is also very tightly regulated at every step. Right from the stage of manufacture of pressure vessels to maintaining them with regular filing of compliance requires clearances from recognized inspectors/ competent persons. The PESO official website (As on 30 th April 2021) enlists only 316 recognized inspectors/ competent persons with valid licenses across India, with wide regional disparities (Table 1). State/ UT Number of recognized Competent Person/Inspector with valid license under SMPV (U) Rules 2016 ANDAMAN NICOBAR 0 ANDHRA PRADESH 2 ARUNACHAN PRADESH 0 ASSAM 2 BIHAR 0 CHHATTISGARH 0 CHANDIGARH 0 DAMAN DIU 0 DELHI 15 DADAR & NAGAR HAWELI 0 GOA 0 GUJARAT 42 HARYANA 1 HIMACHAL PRADESH 0 JHARKHAND 0 JAMMU KASHMIR 0 KARNATAKA 12 KERALA 10 LAKASHADWEEP 0 MEGHALAYA 0 MAHARASTRA 133 MANIPUR 0 MADHYA PRADESH 2 MIZORAM 0 NAGALAND 0 ODISHA 0 PUNJAB 3 PONDICHERRY 0 RAJASTHAN 0 SIKKIM 0 TELANGANA 6 TAMILNADU 20 TRIPURA 0 UTTARAKAND 0 UTTAR PRADESH 19 WEST BANGAL 49 GRAND TOTAL 316 Table 1: State-wise distribution of recognized competent person/ inspector under SMPV (U) Rules 2016 (Source: PESO official website as on 30 th April 2021) The shortage of LOX containers and trucks has surfaced in the light of increase in demand. The Government is grappling with these problems by relaxing certain norms and diverting resources from other industries. Use of ISO tank containers for domestic LOX transport has been allowed(11). Tankers that were being used for liquid nitrogen/ argon and LNG (Liquefied Natural Gas) are being converted for liquid oxygen(12)(13). The renewal process has also been relaxed to fasten the processes(14). Yet again the information gaps are evident from the recent circulars(9), wherein the regulators do not have real-time information about the inventory status. Figure 3 outlines the processes involved in oxygen supply through containers/ pressure vessels and highlights the bottlenecks. iv. Transportation: Transportation of oxygen from source to end-usersis a key aspect and is tightly regulated as well. The conditions of license have strict regulations on all aspects ranging from where these vehicles can be parked, their routes, manpower aspects among others. Provisions in the Motor Vehicle Act 1988 regulate the inter-district, intra-state and inter-state movement of these vehicles with restricted timings for plying on roads. In view of the crises the government has intervened at this level as well by relaxing the norms and allowed free movement of oxygen carrying vehicles across all states and issued orders to this effect as well (15). Despite these steps, problems persisted and there was a need for closer monitoring. Recently, Vehicle Location Tracking (VLT) on all oxygen tankers has been ordered for better tracking and real-time information on inventory(16). The pandemic has therefore compelled relaxation of norms and adoption of technology, which otherwise would have been unlikely. v. Hospital/ end users: The end user base is diverse ranging from large tertiary care hospitals to small nursing homes & clinics and spread wide across the country. The hospital/ healthcare establishments also need to have necessary licenses depending on whether their oxygen requirements are met through cylinders or LOX. There is no real-time data onconsumption patterns or requirement of oxygen in hospitals, which is yet another blind spot for both industry and policy-makers. Data-driven decision-making is at the heart of efficient industry and effective policies. In the absence of credible data, both seem to have suffered over the years and in-turn stifled response to the surge created by the pandemic. Whether to prevent hoarding, black-marketing or to rationalize distribution of oxygen to different hospitals, availability of quality data would have made a huge difference. Discussion It is unequivocally clear from the value stream mapping approach that the entire supply chain right from the point of oxygen manufacture, storage, and transport to the point of consumption is fraught with regulatory bottlenecks . These have double detrimental effects. Firstly, the mainstream/ formal system is rendered inefficient with many wasteful steps that render the existing industry less amenable for changes and deters new entrants. This translates to inability to quickly adapt during crises situation like the current pandemic. Secondly, such a rigid, restrictive system strongly incentivizes mushrooming of informal sector, which starts fulfilling the needs of smaller users who cannot afford the cost and time overruns of red tape.Wherever there is demand, supply will always finds its way. The grey or black-market flourish under such circumstances to meetthe needs of small setups like nursing homes, clinics etc. who cater to the masses. The government or regulators do not have any data on thesegrey/ black markets and consequently are unable to regulate them. This means a significant segment of healthcare could possibly be using medical oxygen from sources where neither quality nor safety can be ascertained. This also reflects in the inability of the government to control black marketing during current crisis. There is almost no real-time data even from the formal channel. The recent circulars mandating daily reporting of inventory status reiterates the same. A robust system requires seamless information flow between all stakeholders, which is clearly lacking in this case. Imagine the government had real-time data on oxygen manufactured, number of cylinders/LOX containers/ LOX trucks, their distribution, quality checks and filling status, the current situation could have definitely been better managed with data driven policiesrather than reactive ones. Industry players could haveinnovated and geared up for changing needs and the hospitals/ end users could haveimproved their systems, as information networks closely knit the ecosystem (Figure 4). The existing system has certainly faltered during the pandemic, with hospitals turning away patients requiring oxygen support or ventilators(17). The domestic industry is not able to meet the rising demand, which has forced to government to look for import of oxygen(17). Unless we substantially change the system- the biomedical, maintenance, distribution and the economic purchasing system for medical oxygen, we would certainly be back in the same situation in 5 years(18). Davidescu et al studied the main characteristics and perspectives of Romanian Medical oxygen market. The study found that the Romanian medical oxygen market is an oligopoly with a small number of producers and had significant segmentations(19).Even in the current study it was found that the medical oxygen ecosystem in India is tightly regulated, with not many players and significant regulatory bottlenecks. The potential solution to these problems lies in digitization and automation. A study from Xie et al from China emphasizes how predictive modeling and data analytics can be used for optimal allocation of resources in disaster situations like COVID-19, where there is not enough time to ramp up production capacity(20). A location-based ubiquitous crowdsourcing approach for emergency supply of oxygen cylinders for patients in need by Barachi et al demonstrates how technology platforms can be leveraged (21). Informational continuity is the foundation for building a credible digital solution(22) for monitoring. Majority of parameters involved in all the processes of medical oxygen are objective and machine-readable. This means KPIs (Key Performance Indicators) can be measured, captured, shared and monitored in near real-time across a common network working on IoT (Internet of Things) or Block chain. This can help to create a robust system with continuous quality improvement as illustrated in Figure 4. Conclusion “Regulation” in the Indian context has unfortunately been more of “Restriction” , which is a colonial hangover. The existing systems are definitely more restrictive rather than regulatory. There is more deterrence and burden on players in the formal/ mainstream who fall under the “Regulatory” ambit, which has its obvious fallouts. Quality and Safety are of paramount importance especially in the medical oxygen industry. Regulation in true sense would actually improve the overall quality and safety by bringing in better monitoring without causing unnecessary obstructions in the process-flow.By leveraging technology the government can not only improve monitoring but also make it easy for the industry to grow. Industry players can be incentivized to shift from the informal side to the mainstream by simplifying the process, which can be a game-changer. Bringing in technology based data-driven regulatory processes with minimum discretionary human interface is the way forward. Digital India Mission and its components like e-Governance have been creating remarkable ease for citizens & businesses in other sectors. The current crisis opens an opportunity to introspect & revamp the medical oxygen industry with digitization and align it with Make in India initiative. We can start by acknowledging fallouts of red-tapism, the elephant in the room . Declarations Funding statement: This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. Conflict of Interest: None Data sharing statement: All relevant data is part of the manuscript and is being shared. Patient consent: Not Applicable Ethics Committee approval: Not Applicable Contributorship Statement: The study was conceptualized by Dr. Naveen R Gowda and Dr. Vikas H. Necessary data collection, review of official circulars, memos, government gazette notifications relevant to the study was done by all authors, findings were discussed and factored-in. Visualization was prepared by Dr. Naveen R Gowda which was reviewed by Dr. Vijaydeep Siddharth and Dr. Parmeshwar Kumar. Dr. Naveen R Gowda prepared the manuscript and all the authors reviewed & approved it. Dr. Amitesh Khare, Dr. Prakash Swaminathan and Dr. Atul Kumar also supported in curating references. References Ministry of Health & Family Welfare G of I. “Supply of oxygen for industrial purposes by manufacturers and suppliers to be prohibited from 22/4/21” Dt: 18/04/21 [Internet]. Government of India; 2021 p. D.O.No.17/S(HFW)/MO/2021. Available from: https://aiigma.org/wp-content/uploads/2021/04/D.O.-Letter-to-HS-Medical-Oxygen-Supply- 18-April-2021.pdf HLL Lifecare Ltd. “SHORT TERM GLOBAL TENDER ENQUIRY DOCUMENT FOR PROCUREMENT OF IMPORTED LIQUID MEDICAL OXYGEN” 16/04/21 [Internet]. Government of India; 2021 p. Tender No. HLL/SOURCING/COVID-19/018-RT/2021. Available from: https://aiigma.org/wp-content/uploads/2021/04/TED_OXYGEN-Import-Tender-HLL-final-16.04.pdf The Gazette of India E. “Price control order for medical oxygen” Dt 25/09/21 [Internet]. India: Extraordinary, PART II- Section 3- Sub-section (ii); 2021 p. CG-DL-E-26092020-222006. Available from: https://aiigma.org/wp-content/uploads/2020/09/222006.pdf Central Drugs Standard Control Organization (CDSCO). “Granting permission to manufacture of industrial oxygen to manufacture oxygen for medical use in the light of COVID-19 Reg” Dt. 07/04/20 [Internet]. India: Government of India; 2020 p. No. DCGI/Misc/2020(96). Available from: https://peso.gov.in/web/updates/granting-permission-manufacturers-industrial-oxygen-manufacture-medical-oxygen Choudhury M, Datta P. Private Hospitals in Health Insurance Network in India: A Reflection for Implementation of Ayushman Bharat. Work Pap. 2019;(254):1–22. PESO. Approved High Pressure Gas Cylinder Manufacturers-PESO [Internet]. 2021. p. As on 30th April 2021. Available from: http://www.peso.gov.in/web/approved-high-pressure-gas-cylinder-manufacturers PESO. Multi Function Valves Manufacturers-PESO [Internet]. 2021. p. As on 30th April 2021. Available from: http://www.peso.gov.in/web/multi-function-valves-manufacturers PESO. “Reduction in compliance burden-introduction of third party for prototype and batch-wise inspection of cylinders, valve & regulators-Reg” Dt. 05/04/21 [Internet]. India: Government of India; 2021 p. No.CVIII(3)125/CIR/GCR. Available from: http://www.peso.gov.in/web/updates/reduction-compliance-burden-tpia-under-gas-cylinders-rules-2016 PESO. “Additional conditions for form-E, form-F GCR 2016 and form LS-1A under SMPV(U) Rules 2016-Daily update of inventory”- Dt 24/07/20 [Internet]. India: Government of India; 2020 p. No.R.1(1)158/II/2020. Available from: https://peso.gov.in/web/updates/additional-conditions-form-e-f-and-ls-1-under-smpvu-rules PESO. “Monitoring the inventory of liquid oxygen/medical oxygen in the country to ensure uninterrupted supply of ocygen to hospitals and other healthcare facilities due to nationwide lockdown for containment of COVID-19 pandemic” Dt. 18/04/2020 [Internet]. India: Government of India; 2020 p. D-21013/PBL/18-Exp. Available from: https://peso.gov.in/web/updates/circular-monitoring-inventory-liquid-oxygen-medical-oxygen PESO. “Approval of ISO Tank Containers for Oxygen” [Internet]. India: Government of India; Available from: https://aiigma.org/wp-content/uploads/2020/09/Approval-of-ISO-Tank-Container-for-Liquid-Oxygen.pdf PESO. “Permission for conversion of liquid Argon & Nitrogen road tankers into service of liquid oxygen” 14/04/21 [Internet]. Government of India; 2021 p. No.R.1(1)158/XI/20. Available from: https://aiigma.org/wp-content/uploads/2021/04/1-1.pdf PESO. “Change in service of the cryogenic gas to be transported” 17/08/20. Government of India; 2020 p. No.R1(1)158/11/2020. PESO. “Relaxation in rules to ease the availability of medical oxygen” 26/04/21 [Internet]. Government of India; 2021 p. D-18019/Comp/Implementation. Available from: https://peso.gov.in/web/updates/relaxation-rules-ease-availability-medical-oxygen-second-wave-covid-19 The Gazette of India E. “MINISTRY OF ROAD TRANSPORT AND HIGHWAYS ORDER EXEMPTING OXYGEN CARRYING VEHICLES” Dt. 21/09/21 [Internet]. India: Extraordinary, PART II- Section 3- Sub-section (ii); 2020 p. CG-DL-E-21092020-221846. Available from: https://aiigma.org/wp-content/uploads/2020/09/SO-3204-E-dated-21st-Septemebr-2020-carriage-of-oxygen-by-transport-vehicle-COVID-19-.pdf Ministry of Road Transport & Highways. “Fixing of VLT devices on vehicles carrying oxygen (Oxygen containers)” 24/04/21 [Internet]. 2021 p. No.RT-23018/37/2021-T. Available from: https://aiigma.org/wp-content/uploads/2021/04/fixing-of-VLT-deviceson-Oxygen-carrying-vehicles-24April2021.pdf Bhuyan A. Covid-19: India looks to import oxygen as cases surge, overwhelming hospitals. BMJ [Internet]. 2021;373:n1061. Available from: http://www.ncbi.nlm.nih.gov/pubmed/33888471 Usher AD. Medical oxygen crisis: a belated COVID-19 response. Lancet (London, England) [Internet]. 2021;397(10277):868–9. Available from: http://dx.doi.org/10.1016/S0140-6736(21)00561-4 Davidescu AA, Apostu SA, Stanciu-Mandruleanu C. Shedding Light on the Main Characteristics and Perspectives of Romanian Medicinal Oxygen Market. Healthcare. 2021;9(2):155. Xie J, Tong Z, Guan X, Du B, Qiu H, Slutsky AS. Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med [Internet]. 2020;46(5):837–40. Available from: https://doi.org/10.1007/s00134-020-05979-7 El Barachi M, Kamoun F, Hachani A, Belqasmi F, Ben Said A, Amri I. A location-based ubiquitous crowdsourcing approach for the emergency supply of oxygen cylinders. Pers Ubiquitous Comput. 2021;25(1):109–20. Gowda NR, Kumar A, Arya SK, Ha V. The information imperative: To study the impact of informational discontinuity on clinical decision making among doctors. BMC Med Inform Decis Mak. 2020;20(1):1–10. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-1120913","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Short Report","associatedPublications":[],"authors":[{"id":66422851,"identity":"3e2b085f-54ab-4336-96a8-b27071a49b94","order_by":0,"name":"Dr. Naveen R Gowda","email":"","orcid":"","institution":"AIIMS New Delhi","correspondingAuthor":false,"submittingAuthor":false,"prefix":"Dr.","firstName":"Naveen","middleName":"R","lastName":"Gowda","suffix":""},{"id":66422852,"identity":"5752bedf-08ea-4ef6-a671-f3920f00afb4","order_by":1,"name":"Dr. Vijaydeep Siddharth","email":"","orcid":"","institution":"AIIMS New Delhi","correspondingAuthor":false,"submittingAuthor":false,"prefix":"Dr.","firstName":"Vijaydeep","middleName":"","lastName":"Siddharth","suffix":""},{"id":66422853,"identity":"bc3876a4-fcbe-4cbd-b653-6e7fa3384738","order_by":2,"name":"Dr. Parmeshwar Kumar","email":"","orcid":"","institution":"AIIMS New Delhi","correspondingAuthor":false,"submittingAuthor":false,"prefix":"Dr.","firstName":"Parmeshwar","middleName":"","lastName":"Kumar","suffix":""},{"id":66422854,"identity":"66f2e852-2229-494f-a96a-3dfca8dfdd54","order_by":3,"name":"Dr. Vikas H","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA40lEQVRIiWNgGAWjYDACZiAEAsaGw8wHGBIMwGIGxGphSyBSCwNMywEeuEr8WgyOMz825vllJ9t3nOfjhwcF2+wZ2Ju3SeDVcpjNOJm3L9l45mHezRIJBrcTG3iOleHVItnMw3yYt4c5ccNh3g0gLQkMEjlmxGipB2rhefwDqMWeQf4Nfi38zDzMyTw/DoO0sIFsYWyQ4CGkhc3YcG7DcaBf2MwsQH5p40krtsCnhY3/8GOJN3+qZfvOH35888ef2/b87Ic33sCnBQSYeNuQDSGkHAQYf/whRtkoGAWjYBSMWAAA/LBJGtEte3UAAAAASUVORK5CYII=","orcid":"","institution":"AIIMS New Delhi","correspondingAuthor":true,"submittingAuthor":false,"prefix":"Dr.","firstName":"Vikas","middleName":"","lastName":"H","suffix":""},{"id":66422855,"identity":"6f716bd6-7702-4da1-afbf-7ead25f102ff","order_by":4,"name":"Dr. Amitesh Khare","email":"","orcid":"","institution":"AIIMS New Delhi","correspondingAuthor":false,"submittingAuthor":false,"prefix":"Dr.","firstName":"Amitesh","middleName":"","lastName":"Khare","suffix":""},{"id":66422856,"identity":"72b93fbd-a7d1-4ee1-8332-4aa5e997c3ef","order_by":5,"name":"Dr. Prakash Swaminathan","email":"","orcid":"","institution":"AIIMS New Delhi","correspondingAuthor":false,"submittingAuthor":false,"prefix":"Dr.","firstName":"Prakash","middleName":"","lastName":"Swaminathan","suffix":""},{"id":66422857,"identity":"e78266bc-969a-48b9-8f71-a23cff91c4f0","order_by":6,"name":"Dr. Atul Kumar","email":"","orcid":"","institution":"ESIC, New Delhi","correspondingAuthor":false,"submittingAuthor":false,"prefix":"Dr.","firstName":"Atul","middleName":"","lastName":"Kumar","suffix":""}],"badges":[],"createdAt":"2021-11-28 09:25:20","currentVersionCode":1,"declarations":{"humanSubjects":false,"vertebrateSubjects":false,"conflictsOfInterestStatement":true,"humanSubjectEthicalGuidelines":false,"humanSubjectConsent":false,"humanSubjectClinicalTrial":false,"humanSubjectCaseReport":false,"vertebrateSubjectEthicalGuidelines":false,"coiExplicitlySet":false},"doi":"10.21203/rs.3.rs-1120913/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-1120913/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":16034780,"identity":"683aa878-f029-4ac4-a5eb-a1d7abbe2be1","added_by":"auto","created_at":"2021-11-30 18:06:10","extension":"jpg","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":89098,"visible":true,"origin":"","legend":"Overview of the medical oxygen supply chain in India","description":"","filename":"Figure1.jpg","url":"https://assets-eu.researchsquare.com/files/rs-1120913/v1/5494b227562a5337e79d7afd.jpg"},{"id":16034781,"identity":"91a12770-4f7e-4927-bd82-199019e32e20","added_by":"auto","created_at":"2021-11-30 18:06:10","extension":"jpg","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":177273,"visible":true,"origin":"","legend":"Oxygen supply through cylinders","description":"","filename":"Figure2.jpg","url":"https://assets-eu.researchsquare.com/files/rs-1120913/v1/991137fee5b9566d0d02332a.jpg"},{"id":16034785,"identity":"44b665c4-b082-4539-abb7-60a7565e98b7","added_by":"auto","created_at":"2021-11-30 18:06:10","extension":"jpg","order_by":3,"title":"Figure 3","display":"","copyAsset":false,"role":"figure","size":163283,"visible":true,"origin":"","legend":"Oxygen supply through pressure vessels","description":"","filename":"Figure3.jpg","url":"https://assets-eu.researchsquare.com/files/rs-1120913/v1/4283068c7502d058be590606.jpg"},{"id":16034783,"identity":"3138ea6b-f7d4-41e0-b27b-62e01411f0ca","added_by":"auto","created_at":"2021-11-30 18:06:10","extension":"jpg","order_by":4,"title":"Figure 4","display":"","copyAsset":false,"role":"figure","size":44014,"visible":true,"origin":"","legend":"Ideal information flow between stakeholders and Continuous Quality Improvement for a robust system","description":"","filename":"Figure4.jpg","url":"https://assets-eu.researchsquare.com/files/rs-1120913/v1/4ae9b67f23ac9d8aea6bae1c.jpg"},{"id":16034787,"identity":"9855d305-ffd4-4f80-a301-dea462df7d54","added_by":"auto","created_at":"2021-11-30 18:06:13","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":610972,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-1120913/v1/8a2815d8-0804-404f-92e3-8c3f0ceb4f02.pdf"}],"financialInterests":"","formattedTitle":"\u003cp\u003eConstrained medical oxygen supply chain in India during COVID-19: Red-tapism, the elephant in the room?\u003c/p\u003e","fulltext":[{"header":"Summary","content":"\u003cp\u003e\u003cstrong\u003eSummary Box:\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat is already known about this subject?\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n \u003cli\u003eShortage of medical oxygen during the second wave of COVID-19 has caused severe crisis in Indian healthcare.\u003c/li\u003e\n \u003cli\u003eGovernment of India has taken drastic steps to address the crisis.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWhat does this study add?\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n \u003cli\u003eValue Stream Mapping approach has been used to study the medical oxygen supply chain in India.\u003c/li\u003e\n \u003cli\u003eInsights on regulatory bottlenecks at different levels of medical oxygen supply chain\u003c/li\u003e\n \u003cli\u003eProvides possible reasons behind the ongoing medical oxygen crisis.\u003c/li\u003e\n \u003cli\u003eProposes plausible long-term systemic solutions for the problem.\u003c/li\u003e\n \u003cli\u003eNo such study till date from India, therefore first of its kind.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cstrong\u003eRecommendations for Policy \u0026amp; Practice?\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n \u003cli\u003eThe study proposes a technology based data-driven regulatory processes with minimum discretionary human interface.\u003c/li\u003e\n \u003cli\u003eBetter ease-of-doing business for the medical oxygen industry.\u003c/li\u003e\n \u003cli\u003eSystemic changes that can further improve regulation and yet keep processes easy for all stakeholders.\u003c/li\u003e\n \u003cli\u003eCan be used to improve government policy making, from reactive to being more proactive.\u003c/li\u003e\n\u003c/ul\u003e"},{"header":"Background","content":"\u003cp\u003eToday entire humanity is grappling with the deadly impact of the COVID 19, which is rapidly mutating and changing its nature as it travels across world. Second wave of COVID 19 caught India by complete surprise and policy paralysis has further weakened the situation in the entire country.It has pushed Indian healthcare to the brink. The fast rising pandemic has uncovered many long-standinginherent weaknesses in the Indian healthcare system.\u003c/p\u003e\n\u003cp\u003eRecent disruption in supply of medical oxygen to healthcare establishments has struck at the very heart of the healthcare system and triggered an alarm at the national level. The crisis has put not just the executive \u0026amp; government but also the judiciary into an overdrive. Oxygen from industries has been diverted for medical purposes among many other radical moves and yet the crisis looms big.\u003c/p\u003e\n\u003cp\u003eSo, what got us here? As with any disaster situation, there are many schools of thought and needless to say, because of its political ramifications, oversimplifying the problem by vilifying select few stakeholders appears to be an easy way out. Some narratives point to a deficient production capacity, which is not agreed by some experts. Failures to maintain supply chain, a surge in consumption, irrational usage, hoarding among others are vaguely tossed around to be the cause.\u003c/p\u003e\n\u003cp\u003eIt is therefore important to have an objective assessment of the system right from the point of production, all the way to the point of consumption/ usage of medical oxygen. This can help us understand the bottlenecks and improvements can be planned at a systemic level to avert future disasters. Value Stream Mapping helps in identifying wasteful activities, improve efficiencyof systems by studying the flow of materials and information. An assessment of the medical oxygen supply chain along this approach can shed more light on the possible causes, which has been done in the current study.\u003c/p\u003e"},{"header":"Aim","content":"\u003cp\u003eTo study the medical oxygen supply chain along the principles of value stream mapping, identify bottlenecks and recommend improvements.\u003c/p\u003e"},{"header":"Methodology","content":"\u003col\u003e\n \u003cli\u003eProcess mapping of medical oxygen supply chain was done with an approach of value stream mapping. It was done in lines with Gas Cylinder Rules 2016 (GCR 2016) and Static \u0026amp; Mobile Pressure Vessels (Unfired) Rules 2016 (SMPV 2016). Different approvals, licenses required, conditions of licenses, renewal of licenses, inspections among others were studied and factored in.\u003c/li\u003e\n \u003cli\u003eAll relevant circular, official orders, memos, amendments, Government of India gazette notifications pertaining to medical oxygen from April 2020 were studied and findings incorporated.\u003c/li\u003e\n \u003cli\u003eRelevant information pertaining to each step in the process mapping was taken from PESO (Petroleum \u0026amp; Explosives Safety Organization) official website (\u003ca href=\"http://www.peso.gov.in\"\u003ewww.peso.gov.in\u003c/a\u003e) and findings incorporated.\u003c/li\u003e\n\u003c/ol\u003e"},{"header":"Results/ Findings","content":"\u003cp\u003eProcess mapping of medical oxygen supply chain was done. It starts with the manufacture of oxygen, followed by largely two streams viz, oxygen cylinders and liquid oxygen. Figure 1 provides an overview of the entire supply chain along with licenses required/ statutory requirements for each step, right from the point of production all the way to the point of consumption/ end users. The entire system can be studied in 5 parts viz,\u003c/p\u003e\n\u003col style=\"list-style-type: lower-roman;\"\u003e\n \u003cli\u003eManufacture of Oxygen,\u003c/li\u003e\n \u003cli\u003eManufacture, filling \u0026amp; storage of cylinders,\u003c/li\u003e\n \u003cli\u003eManufacture, filling \u0026amp; storage of pressure vessels,\u003c/li\u003e\n \u003cli\u003eTransportation and\u003c/li\u003e\n \u003cli\u003eHospitals/ end users\u003c/li\u003e\n\u003c/ol\u003e\n\u003cp\u003e\u003cem\u003ei. Manufacture of oxygen:\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eDemand for medical oxygen during the pandemic has gone up almost four times, from 750MT/day to approx. 2800MT/day. Currently, during the COVID-19 pandemic, around 50% of the total Liquid Oxygen production is being used for medical purpose in comparison to around 15% usage during the pre-COVID period. But the overall production capacity remains more or less the same.\u003c/p\u003e\n\u003cp\u003eThe government has taken measures like diversion of oxygen from other industries(1)and floated a global tender for procurement of Liquid Oxygen(2) in an attempt to tide over the immediate crisis. Financial viability of cylinder fillers was under question due to which the ex-factory price of oxygen was recently capped (3).\u003c/p\u003e\n\u003cp\u003eIn a desperate attempt to boost overall production capacity, Central Drugs Standard Control Organization (CDSCO) issued circular promising license to manufacturers of industrial oxygen to manufacture medical oxygen within 24 hours of applying, under the Drugs \u0026amp; Cosmetics Act 1940 \u0026amp; Rules(4).\u003cem\u003eManufacture of oxygen has therefore been tightly controlled \u0026amp;regulated, which is now being loosened during the crisis.\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eii. Manufacture, filling \u0026amp; storage of cylinders:\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eOxygen delivery through cylinders is one of the key modalities of oxygen supply, especially for small hospitals, nursing homes, day care facilities and remote areas. Around 80% of the hospitals in India are less than 50-bedded(5) and most of them would be dependent on oxygen cylinders for their medical oxygen needs.\u003c/p\u003e\n\u003cp\u003eThe shortage of oxygen cylinders has become more evident during the pandemic. With only 17 approved high-pressure gas cylinder manufactures(6) and 11 approved multi-function valves manufacturers (7), India is undoubtedly grappling with shortage of oxygen cylinders. Government of India has allowed conversion of use of industrial cylinders for filling medical oxygen and floated tender for immediate procurement of oxygen cylinders in a damage control mode.\u003c/p\u003e\n\u003cp\u003eFigure 2 illustrates the complete process of oxygen supply through cylinders and helps to identify the bottlenecks.\u003c/p\u003e\n\u003cp id=\"isPasted\"\u003eThe government has also relaxed the restrictions for filling and storage of oxygen cylinders. Filling of oxygen cylinders round-the-clock has been allowed, which was otherwise not allowed without approval. Even the license renewal process has been relaxed to ease the constraints. Obtaining licenses requires clearances from inspecting authorities, which has been a bottleneck for long. Enabling Third Party Inspection Agencies (TPIAs) for this purpose is a welcome step, but so far there are 15 approved TPIAs across the country(8). Not-to-mention the other approvals from district administration, fire authorities, labor norms etc.\u003c/p\u003e\n\u003cp\u003eSeamless flow of information amongst all stakeholders is the lifeline for any industrial systems. The recent circular instructing all the registered facilities to provide a daily update on the inventory status (9)(10) sheds light on the lack of real-time data with the regulators and possibly tells us the reason for the inertia in the system.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eiii. Manufacture, filling \u0026amp; storage of pressure vessels:\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eThe other important source for larger hospitals and establishments is the liquid oxygen (LOX), which is also very tightly regulated at every step. Right from the stage of manufacture of pressure vessels to maintaining them with regular filing of compliance requires clearances from recognized inspectors/ competent persons. The PESO official website (As on 30\u003csup\u003eth\u003c/sup\u003e April 2021) enlists \u003cem\u003eonly 316 recognized inspectors/ competent persons with valid licenses across India, with wide regional disparities\u003c/em\u003e (Table 1).\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cdiv align=\"center\"\u003e\n \u003ctable border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"549\"\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003e\u003cstrong\u003eState/ UT\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e\u003cstrong\u003eNumber of recognized Competent Person/Inspector with valid license under SMPV (U) Rules 2016\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eANDAMAN NICOBAR\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eANDHRA PRADESH\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e2\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eARUNACHAN PRADESH\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eASSAM\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e2\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eBIHAR\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eCHHATTISGARH\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eCHANDIGARH\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eDAMAN DIU\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eDELHI\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e15\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eDADAR \u0026amp; NAGAR HAWELI\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eGOA\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eGUJARAT\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e42\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eHARYANA\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e1\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eHIMACHAL PRADESH\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eJHARKHAND\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eJAMMU KASHMIR\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eKARNATAKA\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e12\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eKERALA\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e10\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eLAKASHADWEEP\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eMEGHALAYA\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eMAHARASTRA\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e133\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eMANIPUR\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eMADHYA PRADESH\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e2\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eMIZORAM\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eNAGALAND\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eODISHA\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003ePUNJAB\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e3\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003ePONDICHERRY\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eRAJASTHAN\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eSIKKIM\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eTELANGANA\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e6\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eTAMILNADU\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e20\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eTRIPURA\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eUTTARAKAND\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eUTTAR PRADESH\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e19\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003eWEST BANGAL\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e49\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"bottom\" width=\"34.06193078324226%\"\u003e\n \u003cp\u003e\u003cstrong\u003eGRAND TOTAL\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"bottom\" width=\"65.93806921675774%\"\u003e\n \u003cp\u003e\u003cstrong\u003e316\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003c/tbody\u003e\n \u003c/table\u003e\n\u003c/div\u003e\n\u003cp\u003e\u003cstrong\u003eTable 1: State-wise distribution of recognized competent person/ inspector under SMPV (U) Rules 2016 (Source: PESO official website as on 30\u003csup\u003eth\u003c/sup\u003e April 2021)\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe shortage of LOX containers and trucks has surfaced in the light of increase in demand. \u0026nbsp; The Government is grappling with these problems by relaxing certain norms and diverting resources from other industries. Use of ISO tank containers for domestic LOX transport has been allowed(11). Tankers that were being used for liquid nitrogen/ argon and LNG (Liquefied Natural Gas) are being converted for liquid oxygen(12)(13). The renewal process has also been relaxed to fasten the processes(14).\u003c/p\u003e\n\u003cp\u003eYet again the information gaps are evident from the recent circulars(9), wherein the regulators do not have real-time information about the inventory status. Figure 3 outlines the processes involved in oxygen supply through containers/ pressure vessels and highlights the bottlenecks.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eiv. Transportation:\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eTransportation of oxygen from source to end-usersis a key aspect and is tightly regulated as well. The conditions of license have strict regulations on all aspects ranging from where these vehicles can be parked, their routes, manpower aspects among others. Provisions in the Motor Vehicle Act 1988 regulate the inter-district, intra-state and inter-state movement of these vehicles with restricted timings for plying on roads.\u003c/p\u003e\n\u003cp\u003eIn view of the crises the government has intervened at this level as well by relaxing the norms and allowed free movement of oxygen carrying vehicles across all states and issued orders to this effect as well (15). Despite these steps, problems persisted and there was a need for closer monitoring. Recently, Vehicle Location Tracking (VLT) on all oxygen tankers has been ordered for better tracking and real-time information on inventory(16). The pandemic has therefore compelled relaxation of norms and adoption of technology, which otherwise would have been unlikely.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003ev. Hospital/ end users:\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eThe end user base is diverse ranging from large tertiary care hospitals to small nursing homes \u0026amp; clinics and spread wide across the country. The hospital/ healthcare establishments also need to have necessary licenses depending on whether their oxygen requirements are met through cylinders or LOX. There is no real-time data onconsumption patterns or requirement of oxygen in hospitals, which is yet another blind spot for both industry and policy-makers.\u003c/p\u003e\n\u003cp\u003eData-driven decision-making is at the heart of efficient industry and effective policies. In the absence of credible data, both seem to have suffered over the years and in-turn stifled response to the surge created by the pandemic. Whether to prevent hoarding, black-marketing or to rationalize distribution of oxygen to different hospitals, availability of quality data would have made a huge difference.\u003c/p\u003e"},{"header":"Discussion","content":"\u003cp\u003eIt is \u003cem\u003eunequivocally clear\u003c/em\u003efrom the value stream mapping approach that the entire supply chain right from the point of oxygen manufacture, storage, and transport to the point of consumption is fraught with \u003cem\u003eregulatory bottlenecks\u003c/em\u003e. These have double detrimental effects. Firstly, the mainstream/ formal system is rendered inefficient with many wasteful steps that render the existing industry less amenable for changes and deters new entrants. This translates to inability to quickly adapt during crises situation like the current pandemic.\u003c/p\u003e\n\u003cp\u003eSecondly, such a rigid, restrictive system strongly incentivizes mushrooming of informal sector, which starts fulfilling the needs of smaller users who cannot afford the cost and time overruns of red tape.Wherever there is demand, supply will always finds its way. The grey or black-market flourish under such circumstances to meetthe needs of small setups like nursing homes, clinics etc. who cater to the masses.\u003c/p\u003e\n\u003cp\u003eThe government or regulators do not have any data on thesegrey/ black markets and consequently are unable to regulate them. This means a significant segment of healthcare could possibly be using medical oxygen from sources where neither quality nor safety can be ascertained. This also reflects in the inability of the government to control black marketing during current crisis.\u003c/p\u003e\n\u003cp\u003eThere is almost \u003cem\u003eno real-time data\u003c/em\u003e even from the formal channel. The recent circulars mandating daily reporting of inventory status reiterates the same. A robust system requires seamless information flow between all stakeholders, which is clearly lacking in this case. Imagine the government had real-time data on oxygen manufactured, number of cylinders/LOX containers/ LOX trucks, their distribution, quality checks and filling status, the current situation could have definitely been better managed with data driven policiesrather than reactive ones. Industry players could haveinnovated and geared up for changing needs and the hospitals/ end users could haveimproved their systems, as information networks closely knit the ecosystem (Figure 4).\u003c/p\u003e\n\u003cp id=\"isPasted\"\u003eThe existing system has certainly faltered during the pandemic, with hospitals turning away patients requiring oxygen support or ventilators(17). The domestic industry is not able to meet the rising demand, which has forced to government to look for import of oxygen(17). Unless we substantially change the system- the biomedical, maintenance, distribution and the economic purchasing system for medical oxygen, we would certainly be back in the same situation in 5 years(18).\u003c/p\u003e\n\u003cp\u003eDavidescu et al studied the main characteristics and perspectives of Romanian Medical oxygen market. The study found that the Romanian medical oxygen market is an oligopoly with a small number of producers and had significant segmentations(19).Even in the current study it was found that the medical oxygen ecosystem in India is tightly regulated, with not many players and significant regulatory bottlenecks.\u003c/p\u003e\n\u003cp\u003eThe potential solution to these problems lies in digitization and automation. A study from Xie et al from China emphasizes how predictive modeling and data analytics can be used for optimal allocation of resources in disaster situations like COVID-19, where there is not enough time to ramp up production capacity(20). A location-based ubiquitous crowdsourcing approach for emergency supply of oxygen cylinders for patients in need by Barachi et al demonstrates how technology platforms can be leveraged (21).\u003c/p\u003e\n\u003cp\u003eInformational continuity is the foundation for building a credible digital solution(22) for monitoring. Majority of parameters involved in all the processes of medical oxygen are objective and machine-readable. This means KPIs (Key Performance Indicators) can be measured, captured, shared and monitored in near real-time across a common network working on IoT (Internet of Things) or Block chain. This can help to create a robust system with continuous quality improvement as illustrated in Figure 4.\u003c/p\u003e"},{"header":"Conclusion","content":"\u003cp\u003e \u003cem\u003e\u0026ldquo;Regulation\u0026rdquo;\u003c/em\u003e in the Indian context has unfortunately been more of \u003cem\u003e\u0026ldquo;Restriction\u0026rdquo;\u003c/em\u003e, which is a colonial hangover. The existing systems are definitely more restrictive rather than regulatory. There is more deterrence and burden on players in the formal/ mainstream who fall under the \u003cem\u003e\u0026ldquo;Regulatory\u0026rdquo;\u003c/em\u003e ambit, which has its obvious fallouts.\u003c/p\u003e \u003cp\u003eQuality and Safety are of paramount importance especially in the medical oxygen industry. Regulation in true sense would actually improve the overall quality and safety by bringing in better monitoring without causing unnecessary obstructions in the process-flow.By leveraging technology the government can not only improve monitoring but also make it easy for the industry to grow. Industry players can be incentivized to shift from the informal side to the mainstream by simplifying the process, which can be a game-changer.\u003c/p\u003e \u003cp\u003eBringing in technology based data-driven regulatory processes with minimum discretionary human interface is the way forward. Digital India Mission and its components like e-Governance have been creating remarkable ease for citizens \u0026amp; businesses in other sectors. The current crisis opens an opportunity to introspect \u0026amp; revamp the medical oxygen industry with digitization and align it with Make in India initiative. We can start by acknowledging fallouts of \u003cem\u003ered-tapism, the elephant in the room\u003c/em\u003e.\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eFunding statement:\u0026nbsp;\u003c/strong\u003eThis research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConflict of Interest:\u003c/strong\u003e None\u003c/p\u003e\n\u003cp id=\"isPasted\"\u003e\u003cstrong\u003eData sharing statement:\u0026nbsp;\u003c/strong\u003eAll relevant data is part of the manuscript and is being shared.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePatient consent:\u003c/strong\u003e Not Applicable\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEthics Committee approval:\u003c/strong\u003e Not Applicable\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eContributorship Statement:\u0026nbsp;\u003c/strong\u003eThe study was conceptualized by Dr. Naveen R Gowda and Dr. Vikas H. Necessary data collection, review of official circulars, memos, government gazette notifications relevant to the study was done by all authors, findings were discussed and factored-in. Visualization was prepared by Dr. Naveen R Gowda which was reviewed by Dr. Vijaydeep Siddharth and Dr. Parmeshwar Kumar. Dr. Naveen R Gowda prepared the manuscript and all the authors reviewed \u0026amp; approved it. Dr. Amitesh Khare, Dr. Prakash Swaminathan and Dr. Atul Kumar also supported in curating references.\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\u003cli\u003e\u003cspan\u003eMinistry of Health \u0026amp; Family Welfare G of I. \u0026ldquo;Supply of oxygen for industrial purposes by manufacturers and suppliers to be prohibited from 22/4/21\u0026rdquo; Dt: 18/04/21 [Internet]. Government of India; 2021 p. D.O.No.17/S(HFW)/MO/2021. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://aiigma.org/wp-content/uploads/2021/04/D.O.-Letter-to-HS-Medical-Oxygen-Supply-\u003c/span\u003e\u003c/span\u003e18-April-2021.pdf\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eHLL Lifecare Ltd. \u0026ldquo;SHORT TERM GLOBAL TENDER ENQUIRY DOCUMENT FOR PROCUREMENT OF IMPORTED LIQUID MEDICAL OXYGEN\u0026rdquo; 16/04/21 [Internet]. Government of India; 2021 p. Tender No. HLL/SOURCING/COVID-19/018-RT/2021. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://aiigma.org/wp-content/uploads/2021/04/TED_OXYGEN-Import-Tender-HLL-final-16.04.pdf\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eThe Gazette of India E. \u0026ldquo;Price control order for medical oxygen\u0026rdquo; Dt 25/09/21 [Internet]. India: Extraordinary, PART II- Section 3- Sub-section (ii); 2021 p. CG-DL-E-26092020-222006. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://aiigma.org/wp-content/uploads/2020/09/222006.pdf\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eCentral Drugs Standard Control Organization (CDSCO). \u0026ldquo;Granting permission to manufacture of industrial oxygen to manufacture oxygen for medical use in the light of COVID-19 Reg\u0026rdquo; Dt. 07/04/20 [Internet]. India: Government of India; 2020 p. No. DCGI/Misc/2020(96). Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://peso.gov.in/web/updates/granting-permission-manufacturers-industrial-oxygen-manufacture-medical-oxygen\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eChoudhury M, Datta P. Private Hospitals in Health Insurance Network in India: A Reflection for Implementation of Ayushman Bharat. Work Pap. 2019;(254):1\u0026ndash;22.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePESO. Approved High Pressure Gas Cylinder Manufacturers-PESO [Internet]. 2021. p. As on 30th April 2021. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttp://www.peso.gov.in/web/approved-high-pressure-gas-cylinder-manufacturers\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePESO. Multi Function Valves Manufacturers-PESO [Internet]. 2021. p. As on 30th April 2021. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttp://www.peso.gov.in/web/multi-function-valves-manufacturers\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePESO. \u0026ldquo;Reduction in compliance burden-introduction of third party for prototype and batch-wise inspection of cylinders, valve \u0026amp; regulators-Reg\u0026rdquo; Dt. 05/04/21 [Internet]. India: Government of India; 2021 p. No.CVIII(3)125/CIR/GCR. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttp://www.peso.gov.in/web/updates/reduction-compliance-burden-tpia-under-gas-cylinders-rules-2016\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePESO. \u0026ldquo;Additional conditions for form-E, form-F GCR 2016 and form LS-1A under SMPV(U) Rules 2016-Daily update of inventory\u0026rdquo;- Dt 24/07/20 [Internet]. India: Government of India; 2020 p. No.R.1(1)158/II/2020. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://peso.gov.in/web/updates/additional-conditions-form-e-f-and-ls-1-under-smpvu-rules\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePESO. \u0026ldquo;Monitoring the inventory of liquid oxygen/medical oxygen in the country to ensure uninterrupted supply of ocygen to hospitals and other healthcare facilities due to nationwide lockdown for containment of COVID-19 pandemic\u0026rdquo; Dt. 18/04/2020 [Internet]. India: Government of India; 2020 p. D-21013/PBL/18-Exp. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://peso.gov.in/web/updates/circular-monitoring-inventory-liquid-oxygen-medical-oxygen\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePESO. \u0026ldquo;Approval of ISO Tank Containers for Oxygen\u0026rdquo; [Internet]. India: Government of India; Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://aiigma.org/wp-content/uploads/2020/09/Approval-of-ISO-Tank-Container-for-Liquid-Oxygen.pdf\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePESO. \u0026ldquo;Permission for conversion of liquid Argon \u0026amp; Nitrogen road tankers into service of liquid oxygen\u0026rdquo; 14/04/21 [Internet]. Government of India; 2021 p. No.R.1(1)158/XI/20. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://aiigma.org/wp-content/uploads/2021/04/1-1.pdf\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePESO. \u0026ldquo;Change in service of the cryogenic gas to be transported\u0026rdquo; 17/08/20. Government of India; 2020 p. No.R1(1)158/11/2020.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePESO. \u0026ldquo;Relaxation in rules to ease the availability of medical oxygen\u0026rdquo; 26/04/21 [Internet]. Government of India; 2021 p. D-18019/Comp/Implementation. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://peso.gov.in/web/updates/relaxation-rules-ease-availability-medical-oxygen-second-wave-covid-19\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eThe Gazette of India E. \u0026ldquo;MINISTRY OF ROAD TRANSPORT AND HIGHWAYS ORDER EXEMPTING OXYGEN CARRYING VEHICLES\u0026rdquo; Dt. 21/09/21 [Internet]. India: Extraordinary, PART II- Section 3- Sub-section (ii); 2020 p. CG-DL-E-21092020-221846. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://aiigma.org/wp-content/uploads/2020/09/SO-3204-E-dated-21st-Septemebr-2020-carriage-of-oxygen-by-transport-vehicle-COVID-19-.pdf\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMinistry of Road Transport \u0026amp; Highways. \u0026ldquo;Fixing of VLT devices on vehicles carrying oxygen (Oxygen containers)\u0026rdquo; 24/04/21 [Internet]. 2021 p. No.RT-23018/37/2021-T. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://aiigma.org/wp-content/uploads/2021/04/fixing-of-VLT-deviceson-Oxygen-carrying-vehicles-24April2021.pdf\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBhuyan A. Covid-19: India looks to import oxygen as cases surge, overwhelming hospitals. BMJ [Internet]. 2021;373:n1061. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttp://www.ncbi.nlm.nih.gov/pubmed/33888471\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eUsher AD. Medical oxygen crisis: a belated COVID-19 response. Lancet (London, England) [Internet]. 2021;397(10277):868\u0026ndash;9. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttp://dx.doi.org/10.1016/S0140-6736(21)00561-4\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eDavidescu AA, Apostu SA, Stanciu-Mandruleanu C. Shedding Light on the Main Characteristics and Perspectives of Romanian Medicinal Oxygen Market. Healthcare. 2021;9(2):155.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eXie J, Tong Z, Guan X, Du B, Qiu H, Slutsky AS. Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med [Internet]. 2020;46(5):837\u0026ndash;40. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1007/s00134-020-05979-7\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eEl Barachi M, Kamoun F, Hachani A, Belqasmi F, Ben Said A, Amri I. A location-based ubiquitous crowdsourcing approach for the emergency supply of oxygen cylinders. Pers Ubiquitous Comput. 2021;25(1):109\u0026ndash;20.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eGowda NR, Kumar A, Arya SK, Ha V. The information imperative: To study the impact of informational discontinuity on clinical decision making among doctors. BMC Med Inform Decis Mak. 2020;20(1):1\u0026ndash;10.\u003c/span\u003e\u003c/li\u003e\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"All India Institute of Medical Sciences","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Medical oxygen crisis, Regulatory frameworks, Value Stream Mapping, e-Governance, Digital India, Ease of doing business, Health Policy, Health Services Administration","lastPublishedDoi":"10.21203/rs.3.rs-1120913/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-1120913/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003ch2\u003eBackground:\u003c/h2\u003e \u003cp\u003eRecent disruption of medical oxygen during second wave of COVID-19 has caused nationwide panic. This study attempts to objectively analyze the medical oxygen supply chain in India along the principles of value stream mapping (VSM), identify bottlenecks and recommend systemic improvements.\u003c/p\u003e\u003ch2\u003eMethodology:\u003c/h2\u003e \u003cp\u003eProcess mapping of the medical oxygen supply chain in India was done. Different licenses \u0026amp; approvals, their conditions, compliances, renewals among others were factored-in. All relevant circulars, official orders, amendments and gazette notifications pertaining to medical oxygen since April 2020 were studied and corroborated with information from PESO official website.\u003c/p\u003e\u003ch2\u003eFindings:\u003c/h2\u003e \u003cp\u003eAll steps of medical oxygen supply chain right from oxygen manufacture to filling, storage and transport up to the end users; have regulatory bottlenecks. Consequently flow of materials is sluggish and very poor information flow has aggravated the inherent inefficiencies of the system. Government of India has been loosening regulatory norms at every stage, which is reactive rather than proactive policy making.\u003c/p\u003e\u003ch2\u003eDiscussion:\u003c/h2\u003e \u003cp\u003eRegulatory bottlenecks have indirectly fuelled the informal sector over the years, which is not under Government\u0026rsquo;s control. This has also caused difficulties in clamping down black-marketing and hoarding. Technology enabled, data-driven regulatory processes with minimum discretionary human interface is the way to go.\u003c/p\u003e","manuscriptTitle":"Constrained medical oxygen supply chain in India during COVID-19: Red-tapism, the elephant in the room?","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2021-11-30 18:06:08","doi":"10.21203/rs.3.rs-1120913/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"b1870d4c-6724-46a2-89a8-751d66d9a50b","owner":[],"postedDate":"November 30th, 2021","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":8794403,"name":"Health Economics \u0026 Outcomes Research"}],"tags":[],"updatedAt":"2021-11-30T18:06:08+00:00","versionOfRecord":[],"versionCreatedAt":"2021-11-30 18:06:08","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-1120913","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-1120913","identity":"rs-1120913","version":["v1"]},"buildId":"WrCJVZZCHTDjtuVLN7oU0","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}